Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial - The Lancet
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial - The Lancet
Lupus nephritis: high death rate for voclosporin in Phase III
voclosporin - Twitter Search / Twitter
Aurinia Demonstrates Voclosporin's Superiority over Standard-of-Care in Lupus Nephritis
Don't Count Voclosporin Ophthalmic Solution Out (NASDAQ:AUPH) | Seeking Alpha
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial - The Lancet
Voclosporin: Hope on the Horizon for Lupus Nephritis? in: Kidney News Volume 13 Issue 2 (2021)
Voclosporin for Lupus Nephritis: Interim Analysis of the AURORA 2 Extension Study - ACR Meeting Abstracts
Aurinia Pharmaceuticals: R&D Day Update On Its Clinical Program And Pipeline Development (NASDAQ:AUPH) | Seeking Alpha
LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis, US
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis - Kidney International
Aurinia Demonstrates Voclosporin's Superiority over Standard-of-Care in Lupus Nephritis
Aurinia Demonstrates Voclosporin's Superiority over Standard-of-Care in Lupus Nephritis
Aurinia And Voclosporin In Lupus Nephritis: The Countdown Begins (NASDAQ:AUPH) | Seeking Alpha
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial - The Lancet
FDA Approves Aurinia Pharmaceuticals' LUPKYNIS™ (voclosporin) for Adult Patients
Aurinia And Voclosporin In Lupus Nephritis: The Countdown Begins (NASDAQ:AUPH) | Seeking Alpha
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial - The Lancet
Speed of Remission with the Use of Voclosporin, MMF and Low Dose Steroids: Results of a Global Lupus Nephritis Study - ACR Meeting Abstracts
LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis, US
Summarizing most voclosporin clinical trials | Download Table
dough on Twitter: "$AUPH Positive Ph. III clinical trial results (2019) Approval and launch of voclosporin for the treatment of lupus nephritis (late 2020 – early 2021) Distribution partnerships for voclosporin in
Safety data from clinical trials of voclosporin for plaque psoriasis | Download Table
